Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment

Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment - Banner

What You Will Learn

  • Evaluate the epidemiology, risk factors, comorbidities, and community aspects associated with Heart Failure (HF) to determine best practices for care.
  • Distinguish pathophysiologic characteristics when evaluating and diagnosing HF, including current classifications, genotypes, and phenotypes, to best analyze HF risk stratification, prevention, and management strategies.  
  • Incorporate Guideline-Directed Medical Therapy (GDMT), newer therapies, and interprofessional team strategies into treatment care plans for the management of HF to improve care coordination, communication, and patient outcomes. 

Welcome Video

 

Case Challenges and the HF Care Team

 

We are grateful to these distinguished faculty who contributed to this collection:

Chair

Alison Bailey, MD, FACC
Melvin R. Echols, MD, FACC

 

Faculty

Vanessa Blumer, MD, FACC
Biykem Bozkurt, MD, PhD, FACC 
Javed Butler, MBBS, MPH, MBA, FACC 
Katherine Crawford, PharmD, BCCP, AACC 
Leslie L. Davis, NP, PhD, FACC 
Ersilia M. DeFilippis, MD, FACC, FAHA, FHFSA 
Katherine S. Dodd, DO, FACC 
Keith C. Ferdinand, MD, FACC 
Roberta Florido, MD, MHS 
Lindsay Goolsby, MS, RD, LDN, CDES 
Oksana Kamneva, PharmD, BCCP, BCCCP, CPP 
Prateeti Khazanie, MD, MPH 
Michelle M. Kittleson, MD, PhD, FACC 
Selma F. Mohammed, MBBS, FACC 
Tara E. Schreck, PharmD, BCACP 
Emma Siegel, PharmD, BCACP 
George G. Sokos, DO, FACC 
Estefania Oliveros Soles, MD, MSc, FACC, FAHA, FACP 
Justin M. Vader, MD, FACC 
Clyde W. Yancy, MD, MSc, MACC 

Educational Grant Support Provided By: Bayer AG

Page Launched: August 28, 2025

Android App Download IOS App Download Powered By